| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 188968-51-6 | Cilengitide | C27H40N8O7 |
| 188970-21-0 | Melilotigenin C | C30H48O3 |
| 188970-92-5 | Fmoc-3-[[(Allyloxy)carbonyl]amino]-L-alanine | C22H22N2O6 |
| 188975-30-6 | 3,6-Dihydro-2H-pyran-4-yl trifluoromethanesulfonate | C6H7F3O4S |
| 188975-88-4 | N-Boc-hexahydro-1H-azepin-4-one | C11H19NO3 |
| 188990-13-8 | 1,2,4,5-Tetrahydro-3H-3-benzazepine-2,3-dicarboxylic acid 3-(tert-butyl) 2-methyl ester | C17H23NO4 |
| 189005-44-5 | 6-Methyl-2-(4-methylphenyl)imidazol[1,2-a]-pyridine-3-acetic acid | C17H16N2O2 |
| 189016-90-8 | Naltrexone EP Impurity C | C20H23NO4 |
| 189024-26-8 | 2-Chloro-3,5-difluorobenzoic acid | C7H3ClF2O2 |
| 189028-93-1 | (4S)-3-[5-(4-Fluorophenyl)-1,5-dioxopenyl]-4-phenyl-2-oxazolidinone | C20H18FNO4 |
| 189028-95-3 | (4S)-3-[(5S)-5-(4-Fluorophenyl)-5-hydroxypentanoyl]-4-phenyl-1,3-oxazolidin-2-one | C20H20FNO4 |
| 189035-22-1 | 6-Bromo-2,3-dihydrobenzo[b]furan | C8H7BrO |
| 189038-36-6 | N-[[(5S)-3-[3-Fluoro-4-(4-oxido-4-morpholinyl)phenyl]-2-oxo-5-oxazolidinyl]methyl]acetamide | C16H20FN3O5 |
| 189044-30-2 | trans-4-Ethenylcyclohexanecarboxylic acid | C9H14O2 |
| 189060-13-7 | Lapaquistat acetate | C33H41ClN2O9 |
| 189064-06-0 | N2-Acetyl-L-glutaminyl-L-lysyl-L-leucyl-L-valyl-L-phenylalanyl-L-phenylalaninamide | C42H63N9O8 |
| 189083-81-6 | 2-Bromo-6-(tributylstannyl)pyridine | C17H30BrNSn |
| 189084-57-9 | 2,2',4,6'-Tetrabromodiphenyl ether | C12H6Br4O |
| 189084-58-0 | 2,3,4,4',5,6-Hexabromodiphenyl ether | C12H4Br6O |
| 189084-59-1 | 3,4-Dibromodiphenyl ether | C12H8Br2O |
| 189084-60-4 | 2,4',6-Tribromodiphenyl ether | C12H7Br3O |
| 189084-61-5 | 2,3',4,4'-Tetrabromodiphenyl ether | C12H6Br4O |
| 189084-62-6 | 2,3',4',6-Tetrabromodiphenyl ether | C12H6Br4O |
| 189084-63-7 | 2,4,4',6-Tetrabromodiphenyl ether | C12H6Br4O |
| 189084-64-8 | 2,2',4,4',6-Pentabromodiphenyl ether | C12H5Br5O |
| 189084-65-9 | 2,3,4,5,6-Pentabromodiphenyl ether | C12H5Br5O |
| 189084-66-0 | 2,3',4,4',6-Pentabromodiphenyl ether | C12H5Br5O |
| 189084-67-1 | 2,2',3,4,4',5,6-Heptabromodiphenyl ether | C12H3Br7O |
| 189084-68-2 | 2,3,3',4,4',5,6-Heptabromodiphenyl ether | C12H3Br7O |
| 189089-83-6 | 2-Methyl-1-(phenylsulfonyl)-1H-pyrrolo[2,3-b]pyridine | C14H12N2O2S |
| 189089-91-6 | 1-(Phenylsulfonyl)-1H-pyrrolo[2,3-b]pyridine-2-carboxaldehyde | C14H10N2O3S |
| 189095-82-7 | trans-2-Fluoro-4-(4-propylcyclohexyl)benzoic acid 3,4-difluorophenyl ester | C22H23F3O2 |
| 189096-90-0 | N-methoxy-N-methylisoxazole-3-carboxamide | C6H8N2O3 |
| 189097-35-6 | 5-Bromobenzo[b]naphtho[1,2-d]thiophene | C16H9BrS |
| 189098-29-1 | (6R,7S)-2-Acetyl-2-azabicyclo[2.2.1]hept-5-en-3-one | C8H9NO2 |
| 189101-41-5 | (1S,2R)-2-Aminocyclohexane-1-carboxylic acid | C7H13NO2 |
| 189101-43-7 | (1R,2S)-2-Aminocyclohexane-1-carboxylic acid | C7H13NO2 |
| 189102-97-4 | 5,6-Dichloro-3H-imidazo[4,5-b]pyridine | C6H3Cl2N3 |
| 189109-45-3 | Byzantionoside B | C19H32O7 |
| 189114-61-2 | Silver bis(trifluoromethylsulfonyl)amide | C2AgF6NO4S2 |
| 189116-35-6 | 2-Methylpyrazolo[1,5-a]pyrimidin-5(4H)-one | C7H7N3O |
| 189116-36-7 | 5-Chloro-2-methylpyrazolo[1,5-a]pyrimidine | C7H6ClN3 |
| 189144-54-5 | Phenyl 3-O-(phenylmethyl)-1-thio-beta-D-glucopyranoside | C19H22O5S |
| 189146-15-4 | Darocur 4265 | C22H21O2P.C10H12O2 |
| 189148-50-3 | 1-(2-Hydroxyethyl)-4-[3-(3-methyl-2(3H)-benzothiazolylidene)-1-propenyl]quinolinium tetrafluoroborate | C22H21N2OS.BF4 |
| 189153-10-4 | trans-4-[[(1,1-Dimethylethoxy)carbonyl]amino]cyclohexaneacetic acid | C13H23NO4 |
| 189161-09-9 | 3-Chloro-5-methylbenzonitrile | C8H6ClN |
| 189170-01-2 | L-Seryl-L-tyrosyl-L-leucyl-L-glutaminyl-L-alpha-aspartyl-L-seryl-L-alpha-aspartyl-L-prolyl-L-alpha-aspartyl-L-seryl-L-phenylalanyl-L-glutaminyl-L-aspartic acid | C64H89N15O28 |
| 189188-57-6 | Tegaserod maleate | C16H23N5O.C4H4O4;C20H27N5O5 |
| 189189-12-6 | 4,5:4',5'-Dibenzo-1,1'-dibutyl-3,3,3',3'-tetramethylindocarbocyanine perchlorate | C39H45ClN2O4 |